Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
9,329,591
-
Share change
-
+7,061,082
-
Total reported value
-
$37,876,000
-
Price per share
-
$4.06
-
Number of holders
-
32
-
Value change
-
+$30,074,098
-
Number of buys
-
28
-
Number of sells
-
8
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2017
As of 31 Dec 2017,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,329,591 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., Sio Capital Management, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Park West Asset Management LLC, Opaleye Management Inc., PURA VIDA INVESTMENTS, LLC, EAM Investors, LLC, and EAM Global Investors LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.